T1 High-grade Bladder Cancer: The Search for the Optimal Management Continues

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F18%3A10388782" target="_blank" >RIV/00216208:11130/18:10388782 - isvavai.cz</a>
Alternative codes found
RIV/00064203:_____/18:10388782
Result on the web
<a href="https://doi.org/10.1016/j.eururo.2018.08.016" target="_blank" >https://doi.org/10.1016/j.eururo.2018.08.016</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.eururo.2018.08.016" target="_blank" >10.1016/j.eururo.2018.08.016</a>

Result language
angličtina
Original language name
T1 High-grade Bladder Cancer: The Search for the Optimal Management Continues
Original language description
On reading the article "Treatment strategy for newly diagnosed T1 high-grade (HG) bladder urothelial carcinoma" by Klaasen et al. in this month's issue of European Urology, a urologist who retired 25 yr ago could be forgiven for thinking that little has changed since then in the management of this disease. Whilst early repeat transurethral resection (re-TUR) has become standard practice and the 1973 grading classification has been supplemented, but not necessarily replaced, by the 2004 grading classification, the mainstay of treatment remains a meticulous TUR of the bladder tumour followed by either intravesical therapy with bacillus Calmette-Guérin (BCG) or radical cystectomy (RC)
Czech name
—
Czech description
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)